Medical treatment of pituitary-dependent hyperadrenocorticism: Mitotane

Veterinary Clinics of North America - Small Animal Practice

Volumn 27, Issue 2, 1997, Pages

  Peterson, M E ^a   Kintzer, P P ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOTANE;

DOG; DRUG EFFICACY; HYPERADRENOCORTICISM; NONHUMAN; REVIEW;

EID: 0030943422     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(97)50030-1     Document Type: Review

References (37)

1. J.D. Baggot Comparative patterns of drug biotransformation Principles of Drug Disposition in Domestic Animals: The Basis of Veterinary Clinical Pharmacology 1977 WB Saunders Philadelphia 73
2. W. Cai R.E. Counsell T. Djanegara Metabolic activation and binding of mitotane in adrenal cortex homogenates J Pharm Sei 84 1995 134
3. C. Cuerto J.H. Brown Biological studies on an adrenocorticolytic agent and the isolation of the active components Endocrinology 62 1958 334
4. F.E. Dreifuss D.H. Langer Hepatic considerations in the use of antiepileptic drugs Epilepsia 28 1987 23
5. K.J. Dunn M.E. Herrtage J.K. Dunn Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism Vet Ree 137 1995 161
6. J.E. Eigenmann M.E. Peterson Diabetes mellitus associated with other endocrine disorders Vet Clin North Am Small Anim Pract 14 1984 837
7. E.C. Feldman R.W. Nelson Diabetes mellitus E.C. Feldman R.W. Nelson Canine and Feline Endocrinology and Reproduction 1996 WB Saunders Philadelphia 339
8. E.C. Feldman R.W. Nelson Hyperadrenocorticism (Cushing's syndrome) E.C. Feldman R.W. Nelson Canine and Feline Endocrinology and Reproduction 1996 WB Saunders Philadelphia 187
9. D.S. Greco E.N. Behrend Corticosteroid withdrawal syndrome J.D. Bonagura R.W. Kirk Kirk's Current Veterinary Therapy XII 1995 WB Saunders Philadelphia 413
10. M.L. Gutierrez S.T. Crooke Mitotane (o, p'-DDD) Cancer Treat Rev 7 1980 49
11. A.J. Kaplan M.E. Peterson R.J. Kemppainen Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs J Am Vet Med Assoc 207 1995 445
12. A.A. Kasperlik-Zaluska J. Nielubowicz J. Wislawski Nelson's syndrome: Incidence and prognosis Clin Endocrinol 19 1983 693
13. P.P. Kintzer M.E. Peterson Mitotane (o, p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism J Vet Intern Med 5 1991 182
14. P.P. Kintzer M.E. Peterson Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms J Am Vet Med Assoc 205 1994 54
15. M.D. Lorenz Diagnosis and medical management of canine Cushing's syndrome: A study of 57 consecutive cases J Am Anim Hosp Assoc 18 1982 707
16. A.J. Moolenaar H. van Slooten A.P. van Seters Blood levels of o, p'-DDD following administration in various vehicles after a single dose and during long-term treatment Cancer Chemother Pharmacol 7 1981 51
17. R.H. Moy Studies of the pharmacology of o, p'-DDD in man J Lab Clin Med 58 1961 296
18. A.A. Nelson G. Woodard Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis (para-chlorophenyl)-l, l-trichloroethane (DDD or TDE) Arch Pathol 48 1949 387
19. R.W. Nelson E.C. Feldman B.A. Shinsako Effect of o, p'-DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism Am J Vet Res 46 1985 1534
20. R.W. Nelson S.L. Ihle E.C. Feldman Pituitary macroadenomas and macroadenocarcino- mas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986) J Am Vet Med Assoc 194 1989 1612
21. C.E. Nichols Endocrine and metabolic causes of polyuria and polydipsia R.W. Kirk J.D. Bonagura Kirk's Current Veterinary Therapy XI 1992 WB Saunders Philadelphia 293
22. M.E. Peterson O, p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism J Am Vet Med Assoc 182 1983 527
23. M.E. Peterson Canine hyperadrenocorticism R. Kirk Current Veterinary Therapy IX 1986 WB Saunders Philadelphia 963
24. M.E. Peterson Diagnosis and management of insulin resistance in dogs and cats with diabetes mellitus Vet Clin North Am Small Anim Pract 25 1995 691
25. M.E. Peterson N. Altszuler C.E. Nichols Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism Res Vet Sci 36 1984 177
26. M.E. Peterson P.P. Kintzer Medical treatment of pituitary-dependent hyperadrenocorticism in dogs Semin Vet Med Surg (Small Anim) 9 1994 127
27. M.E. Peterson D.T. Krieger W.D. Drucker Immunocytochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism Acta Endocrinol 101 1982 15
28. M.E. Peterson G.H. Nesbitt M. Schaer Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs J Am Vet Med Assoc 178 1981 66
29. M.E. Peterson D.N. Orth N.S. Halmi Plasma immunoreactive proopiomelanocortin (POMC) peptides and Cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: Basal concentrations Endocrinology 119 1986 720
30. Product information, Lysodren (mitotane tablets, USP) Bristol Laboratories Oncology Products 1987 Bristol-Myers Squibb Co Princeton, NJ
31. D. Sarfaty J.M. Carrillo M.E. Peterson Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: Eight cases (1976-1984) J Am Vet Med Assoc 193 1988 854
32. R.D. Schechter G.H. Stabenfeldt D.H. Gribble Treatment of Cushing's syndrome in the dog with an adrenocorticolytic agent (o, p'-DDD) J Am Vet Med Assoc 162 1973 629
33. J.W. Simpson A.H.M. Van Den Broek Assessment of fat absorption in normal dogs and in dogs with hyperadrenocorticism Res Vet Sci 48 1990 38
34. P.F. Solter W.E. Hoffmann L.L. Hungerford Assessment of corticosteroid-induced alkaline phosphatase isoenzyme as a screening test for hyperadrenocorticism in dogs J Am Vet Med Assoc 203 1993 534
35. H. van Slooten A.P. van Seters D. Smeenk O, p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy Cancer Chemother Pharmacol 9 1982 85
36. A.D.J. Watson A. Rijnberk A.J. Moolenaar Systemic availability of o, p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism Res Vet Sci 43 1987 160
37. M.D. Willard W.D. Schall R.F. Nachreiner Hypoadrenocorticism following therapy with o, p'-DDD for hyperadrenocorticism in four dogs J Am Vet Med Assoc 180 1982 638